Supplementary protection
LT - Antikūnai prieš GPRC5D, bispecifinį antigeną surišančios molekulės, prijungiančios GPRC5D ir CD3, ir jų naudojimas
EN - ANTI- GPRC5D ANTIBODIES, BISPECIFIC ANTIGEN BINDING MOLECULES THAT BIND GPRC5D AND CD3, AND USES THEREOF
SPC
| (11) |
Number of the document |
|
| (68) |
Number of the document |
3487882
|
| (21) |
Application number for Supplementary Protection Certificate |
PA 2026 501 |
| (22) |
Date of filing the application |
2026-01-12 |
| (41) |
Date of publication of the application |
2026-01-26 |
|
Date of publication of SPC |
|
| (24) |
Date of coming into effect of SPC |
|
Applicant
| (71) |
Janssen Biotech, Inc. ,
800/850 Ridgeview Drive, Horsham, PA 19044,
US
|
Grantee
| (73) |
Janssen Biotech, Inc. ,
800/850 Ridgeview Drive, Horsham, PA 19044,
US
|
Attorney or representative
| (74) |
Stanislava TELEIŠIENĖ,
UAB "Brainera", Taikos 235-17, LT-05213 Vilnius,
LT
|
Number, date and code of the country of origin of the first authorization to place the medicinal or plant protection product on the market within regional economic community
| (93) |
EU/1/23/1748, 2023-08-21
|
Name of the product protected by the basic patent
| (95) |
Talkvetamabas |
Legal status
|
SPC application published
|
|
